Regeneron and Sanofi Announce Plans to Make Praluent® (alirocumab) More Accessible and Affordable for Patients with the Greatest Health Risk and Unmet Need

March 10, 2018

Responsive image

TARRYTOWN, N.Y. and PARIS, March 10, 2018 /PRNewswire/ — To help ensure more affordable and timely access to patients most in need, Regeneron Pharmaceuticals (NASDAQ: REGN) and Sanofi will offer payers that agree to reduce burdensome access barriers for high-risk patients a further…

Category: Precious Metals